These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 27079889)

  • 21. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).
    Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M;
    BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
    Tompkins CM; McNitt S; Polonsky B; Daubert JP; Wang PJ; Moss AJ; Zareba W; Kutyifa V
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):94-102. PubMed ID: 27696593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
    Bolzan B; Morani G; Tomei R; Tomasi L; Borio G; Ribichini FL
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):721-724. PubMed ID: 31389822
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
    Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
    High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond.
    van Dijk VF; Boersma LV
    Trends Cardiovasc Med; 2020 Aug; 30(6):378-384. PubMed ID: 31610949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is defibrillation testing necessary?
    Russo AM; Chung MK
    Cardiol Clin; 2014 May; 32(2):211-24. PubMed ID: 24793798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 34. An Extrapericardial Minimally Invasive Approach for Implantable Cardioverter Defibrillator.
    Madjarov JM; Katz MG; Poole B; Madzharov S; Fedor JM; Robicsek F
    Thorac Cardiovasc Surg; 2017 Sep; 65(6):475-478. PubMed ID: 28324909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The totally subcutaneous implantable defibrillator.
    Rhyner J; Knight BP
    Cardiol Clin; 2014 May; 32(2):225-37. PubMed ID: 24793799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
    Rowin EJ; Burrows A; Madias C; Estes NAM; Link MS; Maron MS; Maron BJ
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008123. PubMed ID: 32897759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients.
    Dichtl W; Wolber T; Paoli U; Brüllmann S; Stühlinger M; Berger T; Spuller K; Strasak A; Pachinger O; Haegeli LM; Duru F; Hintringer F
    Clin Cardiol; 2011 Jul; 34(7):433-6. PubMed ID: 21678454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.